Leaflet BETABIOPTAL 0.2g / 0.5g / 100g ophthalmic ointment

Indicated for: eye or ear infections with inflammation

Route of administration: ophthalmic

Substance: chloramphenicol + betamethasone (antibacterial antibiotic + glucocorticoid)

ATC: S01CA05 (Sensory organs | Antiinflammatory agents and antiinfectives in combination | Corticosteroids and antiinfectives in combination)

Precautions:
Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Glaucoma warning
Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Vision disturbances
Vision disturbances

This medicine may cause vision disturbances.

Chloramphenicol and betamethasone are used in combination in certain medications to treat bacterial infections associated with inflammation. This combination is commonly found in topical products (ointments, creams, or eye/ear drops) and is indicated for conditions such as bacterial conjunctivitis, blepharitis, otitis externa, or other inflammatory skin infections.

Chloramphenicol is a broad-spectrum antibiotic that inhibits bacterial protein synthesis, making it effective against a wide range of gram-positive and gram-negative bacteria. Betamethasone is a corticosteroid with anti-inflammatory and anti-allergic properties, which reduces inflammation, swelling, and itching associated with infections.

While this combination is effective, its use requires caution. Chloramphenicol may cause rare side effects, such as hypersensitivity reactions or, in very rare cases, bone marrow aplasia (a serious bone marrow condition). Betamethasone, if used long-term or in large amounts, can lead to systemic side effects, such as suppression of the hypothalamic-pituitary-adrenal axis, skin thinning, or secondary infections.

This combination should be used as directed by a doctor, and the duration of treatment should be limited to reduce the risk of side effects. It is important to avoid long-term use or application over large areas of the skin. If severe side effects or persistent symptoms occur, immediate medical attention is necessary.

General data about BETABIOPTAL 0.2g / 0.5g / 100g

  • Substance: chloramphenicol + betamethasone
  • Date of latest medicines list: 01-07-2013
  • Product code: W42433001
  • Concentration: 0.2g / 0.5g / 100g
  • Pharmaceutical form: ophthalmic ointment
  • Quantity: 1
  • Product type: Generic medicine
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Pharmaceutical forms available for chloramphenicol + betamethasone

Concentrations available for chloramphenicol + betamethasone

  • 0.2g/0.5g/100g
  • 0.2g/0.5g/100ml